Abstract
Chronic rotator cuff tears are a common source of shoulder pain and disability. Patients with rotator cuff tears often have substantial weakness, fibrosis, and fat accumulation, which limit successful surgical repair and postoperative rehabilitation. The Murphy Roths Large (MRL) strain of mice have demonstrated superior healing and protection against pathological changes in several disease and injury conditions. We tested the hypothesis that, compared with the commonly used C57Bl/6 (B6) strain, MRL mice would have less muscle fiber atrophy and fat accumulation, and be protected against the loss in force production that occurs after cuff tear. Adult male B6 and MRL mice were subjected to a rotator cuff tear, and changes in muscle fiber contractility and histology were measured. RNA sequencing and shotgun metabolomics and lipidomics were also performed. The muscles were harvested one month after tear. B6 and MRL mice had a 40% reduction in relative muscle force production after rotator cuff tear. RNA sequencing identified an increase in fibrosis-associated genes and a reduction in mitochondrial metabolism genes. The markers of glycolytic metabolism increased in B6 mice, while MRL mice appeared to increase amino acid metabolism after tear. There was an accumulation of lipid after injury, although there was a divergent response between B6 and MRL mice in the types of lipid species that accrued. There were strain-specific differences between the transcriptome, metabolome, and lipidome of B6 and MRL mice, but these differences did not protect MRL mice from weakness and pathological changes after rotator cuff tear.
Original language | English |
---|---|
Pages (from-to) | 811-822 |
Number of pages | 12 |
Journal | Journal of Orthopaedic Research |
Volume | 38 |
Issue number | 4 |
DOIs | |
Publication status | Published - Apr 1 2020 |
Bibliographical note
Publisher Copyright:© 2019 Orthopaedic Research Society. Published by Wiley Periodicals, Inc.
Funding
The University of Michigan Metabolomics Core is supported by NIH grant U24‐DK097153. Bioinformatics support was provided by a grant from the Tow Foundation for the David Z. Rosensweig Genomics Center at the Hospital for Special Surgery. We would like to acknowledge technical assistance from Dr. David Oliver and Mr. Damonie Salmon at the Hospital for Special Surgery.
Funders | Funder number |
---|---|
National Institutes of Health | U24‐DK097153 |
National Institute of Arthritis and Musculoskeletal and Skin Diseases | R01AR063649 |
Center for Outcomes Research and Evaluation, Yale School of Medicine | |
University of Michigan | |
Tow Foundation |
ASJC Scopus Subject Areas
- Orthopedics and Sports Medicine